Sio Capital Management »

Avalo Therapeutics Ord shares owned by Sio Capital Management

Quarter-by-quarter ownership of Avalo Therapeutics Ord (AVTX) shares owned by Sio Capital Management from 13F filings

Historical chart of Sio Capital Management investment in Avalo Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Avalo Therapeutics Ord held by Sio Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avalo Therapeutics Ord by Sio Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $221k 10k 21.75

More positions owned by Sio Capital Management

Laboratory Corporation Of America Holdings Com New (LH)
Insmed Com Par $.01 Put Option (INSM)
Cigna Corp (CI)
Globus Medical Cl A (GMED)
Madrigal Pharmaceuticals (MDGL)
GSK Sponsored Adr (GSK)
Zimmer Holdings (ZBH)
Ironwood Pharmaceuticals Com Cl A (IRWD)
Medtronic SHS (MDT)
Organon & Co Common Stock (OGN)
Tyra Biosciences (TYRA)
Embecta Corp Common Stock (EMBC)
Teleflex Incorporated (TFX)
Arcutis Biotherapeutics (ARQT)
Bridgebio Pharma (BBIO)

View all positions for Sio Capital Management

Top funds holding Avalo Therapeutics Ord

Ikarian Capital
Sio Capital Management
UBS Group
ADAR1 Capital Management
Natixis
BlackRock
Tower Research Capital
Banque Cantonale Vaudoise
Royal Bank of Canada
Morgan Stanley
Wells Fargo & Company
Bnp Paribas Arbitrage, Snc
Group One Trading
Jpmorgan Chase & Co
Advisor Group Holdings

View all funds holding Avalo Therapeutics Ord